3, 3′5 Triiodo L Thyronine Induces Apoptosis in Human Breast Cancer MCF-7cells, Repressing SMP30 Expression through Negative Thyroid Response Elements

Background Thyroid hormones regulate cell proliferation, differentiation as well as apoptosis. However molecular mechanism underlying apoptosis as a result of thyroid hormone signaling is poorly understood. The antiapoptotic role of Senescence Marker Protein-30 (SMP30) has been characterized in resp...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2011-06, Vol.6 (6), p.e20861
Main Authors: Sar, Pranati, Peter, Rosalima, Rath, Bandita, Mohapatra, Alok Das, Mishra, Sandip K.
Format: Article
Language:English
Subjects:
Apoptosis
Binding sites
Biology
Breast cancer
Cancer
Cell proliferation
Clonal deletion
Colorectal cancer
Cytometry
Deceleration
Estrogens
Flow cytometry
Gene deletion
Gene expression
Genetic engineering
Histone deacetylase
Hormones
Hypotheses
Life sciences
Ligands
Liver
Lymphoma
Medicine
Metastases
Metastasis
Physiology
Proteins
Regulatory sequences
Senescence
Signaling
siRNA
Thyroid
Thyroid gland
Thyroid hormones
Transcription factors
Triiodothyronine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Thyroid hormones regulate cell proliferation, differentiation as well as apoptosis. However molecular mechanism underlying apoptosis as a result of thyroid hormone signaling is poorly understood. The antiapoptotic role of Senescence Marker Protein-30 (SMP30) has been characterized in response to varieties of stimuli as well as in knock out model. Our earlier data suggest that thyroid hormone 3, 3′5 Triiodo L Thyronine (T3), represses SMP30 in rat liver. Methodology/Principal Findings In highly metastatic MCF-7, human breast cancer cell line T3 treatment repressed SMP30 expression leading to enhanced apoptosis. Analysis by flow cytometry and other techniques revealed that overexpression and silencing of SMP30 in MCF-7 resulted in decelerated and accelerated apoptosis respectively. In order to identify the cis–acting elements involved in this regulation, we have analyzed hormone responsiveness of transiently transfected hSMP30 promoter deletion reporter vectors in MCF-7 cells. As opposed to the expected epigenetic outcome, thyroid hormone down regulated hSMP30 promoter activity despite enhanced recruitment of acetylated H3 on thyroid response elements (TREs). From the stand point of established epigenetic concept we have categorised these two TREs as negative response elements. Our attempt of siRNA mediated silencing of TRβ, reduced the fold of repression of SMP30 gene expression. In presence of thyroid hormone, Trichostatin- A (TSA), which is a Histone deacetylase (HDAC) inhibitor further inhibited SMP30 promoter activity. The above findings are in support of categorisation of both the thyroid response element as negative response elements as usually TSA should have reversed the repressions. Conclusion This is the first report of novel mechanistic insights into the remarkable downregulation of SMP30 gene expression by thyroid hormone which in turn induces apoptosis in MCF-7 human breast cancer cells. We believe that our study represents a good ground for future effort to develop new therapeutic approaches to challenge the progression of breast cancer.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0020861